LG

Lukas Guenther

Life Sciences Venture Capital

Germany

Investor
VC

Invests in

Stages:

Series A
Seed

Sectors:

BioTech

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Lifesciences
Venture Capital
Medical Devices
Start-ups
Biotechnology
Strategy
IPO
Commercialization
Healthcare
Clinical Trials
Entrepreneurship
Clinical Development
Pharmaceutical Industry
Venture Financing
Investments
Technology Transfer
Emerging Markets
Clinical Research
Medtech
Due Diligence

Education

Lists including Lukas

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

EndoRon Medical

Seed

Total Funding: $5M

Work Experience

Es
Endostart s.r.l.

2018

  • Independent Board Member

    2018

SP
Sofinnova Partners

2019 - 2023

  • Partner

    2019 - 2023

    Sofinnova Partners is an independent venture capital firm based in Paris and investing in early-stage companies in Life Sciences. Over the past 40 years, the firm has financed and accompanied almost 500 companies.

MS
MD Start

2018 - 2019

  • Venture Partner

    2018 - 2019

Q
Quobyte

2015 - 2017

  • Investor

    2015 - 2017

Pflege.de

2014 - 2017

  • Board Member

    2014 - 2017

Single Family Office

2014 - 2017

  • Investment Director

    2014 - 2017

C
Crealytics

2014 - 2017

  • Member Board Of Directors

    2014 - 2017

nG
nu3 GmbH

2014 - 2017

  • Board Observer

    2014 - 2017

WP
Wellington Partners

2007 - 2014

  • Investment Director

    2007 - 2014

AyoxxA Pte.Ltd.

2012 - 2014

  • Board Observer

    2012 - 2014

    http://www.ayoxxa.com/

Latest Articles

Medium•Mar. 2017

Digital health is a game changer but data interoperability has to be solved

Healthcare
Health Technology
digital health
data interoperability
eHealth
Medium•Feb. 2017

Sandra Buttigieg, Associate Professor and Head, Department of Health Services Management, Faculty…

Healthcare
Biovision conference
health stakeholders
systems-based approach
One Health
Medium•Feb. 2017

Mike Hardman — VP IMI Collaborations — Astrazeneca

Global Health
Biovision conference
collaboration
scientific community
innovation
Medium•Feb. 2017

Christophe Van Veack — Gimv’s Health & Care

Venture Capital
Startup
Biotechnology
Ehealth
Gimv's Health & Care platform
Medium•Feb. 2017

Dr. Lukas GUENTHER — ALSTIN — Alternative Strategic Investments

Life Science venture capital
corporate involvement
family offices
healthcare payers
VC fund specialization
Medium•Apr. 2016

Véronique Trillet-Lenoir, Présidente du Comité de Direction du Cancéropôle Lyon Rhône-Alpes…

Life
Science
Research
cancer prevention
CLARA (Cancéropôle Lyon Rhône-Alpes Auvergne)
Medium•Apr. 2016

Brigitte Autran, PU-PH d’immunologie à l’Université Pierre et Marie Curie, Directrice du…

Life
Research
Health
innovation vaccinale
CoReVac
Medium•Apr. 2016

Christophe Dercamp, directeur BIOVISION

Life Sciences
Innovation
Health
Biovision
participative approach
Medium•Apr. 2016

Didier Vinot, VP de l’Université Lyon 3 et co-responsable de la Chaire d’études critique des…

Life
Science
Education
Santé Globale
Médecine et Humanités
Medium•Apr. 2016

Dr. Béatrice Fervers, coordinatrice du Département Cancer Environnement du Centre Léon Bérard

Life Sciences
Innovation
Cancer
cancer prevention
risk factors
Medium•Apr. 2016

Florence Agostino, directrice du pôle de compétitivité Lyonbiopole

Biology
Life Sciences
Innovation
digitalization in healthcare
Lyonbiopole
Medium•Apr. 2016

Rebecca Grais, director of research, Epicentre, Médecins Sans Frontières

Africa
Humanitarian
Health
vaccine access
vulnerable populations
Medium•Mar. 2016

Michel Goldman, Founder of the Interdisciplinary Innovation in healthcare (i3h)

Healthcare
Startup
Innovation
interdisciplinary innovation in healthcare
healthcare collaboration
Medium•Mar. 2016

Muriel Malbezin, directeur de la Recherche Clinique et de l’Innovation aux Hospices Civils de Lyon

Innovation
Life Sciences
Research
digital medicine
patient self-monitoring
Medium•Mar. 2016

Professeur Guy Vallancien, Université Paris Descartes

Life Sciences
Innovation
Digital
digital health
patient participation
Medium•Mar. 2016

Dr. Alain Mérieux, président de la Fondation Mérieux

Life
Life Sciences
Innovation
global health approach
multidisciplinary healthcare
Medium•Mar. 2016

Prof. Michel Goldman, Président du comité international de Biovision, Institut for…

Life
Science
Health
Biovision forum
future of medicine
Medium•Mar. 2016

Anne-Marie Graffin, directrice de Biovision Catalyzer et Biovision Investor Conference

Life
Science
Health
Biovision Catalyzer
Biovision Investor Conference
Medium•Feb. 2016

Alexander von Gabain, deputy Vice-chancellor for innovation and commercial outreach at Karolinska…

Startup
Entrepreneurship
Life Sciences
Biovision Catalyzer
startups
Medium•Feb. 2016

Dr. Lukas Guenther, Life Science investment manager at ALSTIN, co-president of Biovision Investment…

Startup
Entrepreneurship
Life Sciences
Biovision Investor Conference
life science companies
Medium•Feb. 2016

Karine Lignel, Venture Capital Director CM-CIC Capital Innovation, co-President of Biovision…

Startup
Venture Capital
Life Sciences
Biovision Investor Conference
lifesciences
Medium•Feb. 2016

Marc Bonneville, VP in charge of scientific and medical affairs at Institut Mérieux and…

Entrepreneurship
Startup
Life Sciences
Biovision Catalyzer
innovation projects
Medium•Jan. 2016

Diabeloop : une start-up Medtech lauréate de Biovision Catalyser 2015

Startup
Francais
Medtech
Diabeloop
artificial pancreas
Medium•Jan. 2016

Frank Bulens, Capricorn Venture Partners

Medicine
Healthcare
Life Sciences vision
convergence of technologies
combination of drugs and delivery devices
Medium•Jan. 2016

Bruno Montanari, Partner at Omnes Capital

Venture Capital
Startup
Biology
Life sciences
ageing populations